Yiliang Zhang

发表

ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.

Lei Wang, Bin Li, Yang Zhang, 2014, Lung cancer.

Are exon 19 deletions and L858R different in early stage lung adenocarcinoma?

Yang Zhang, Haiquan Chen, Yongfu Yu, 2017, Journal of Cancer Research and Clinical Oncology.

Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas

Yang Zhang, Haiquan Chen, Yongfu Yu, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma

Yang Zhang, B. Li, Lei Shen, 2014, Annals of Surgical Oncology.

Is flexible bronchoscopy necessary in the preoperative workup of patients with peripheral cT1N0 subsolid lung cancer? —a prospective multi-center cohort study

Haiquan Chen, Shengping Wang, Jie Gu, 2021, Translational lung cancer research.

Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas

Yang Zhang, Haiquan Chen, Yongfu Yu, 2019, Annals of Surgical Oncology.

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma

Yang Zhang, Haiquan Chen, Jing Li, 2014, Scientific Reports.

A Comprehensive Investigation of Molecular Features and Prognosis of Lung Adenocarcinoma with Micropapillary Component

Yang Zhang, Haiquan Chen, B. Li, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of gentamicin distribution in the inner ear following administration via the endolymphatic sac or round window

Chunfu Dai, P. Steyger, Yongfu Yu, 2010, The Laryngoscope.

P-155ALK, ROS1 AND RET FUSIONS IN 1139 LUNG ADENOCARCINOMAS: A COMPREHENSIVE STUDY OF COMMON AND FUSION PATTERN-SPECIFIC CLINICOPATHOLOGIC, HISTOLOGIC AND CYTOLOGIC FEATURES

Yang Zhang, H. Li, B. Li, 2014 .

Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis.

Yang Zhang, Haiquan Chen, Yihua Sun, 2013, The Annals of thoracic surgery.

Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial

Yang Zhang, Haiquan Chen, B. Li, 2017, Annals of surgery.

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes

Yongfu Yu, J. Xiang, Mathew Thomas, 2022, Frontiers in Oncology.

Comparison of Ivor-Lewis vs Sweet esophagectomy for esophageal squamous cell carcinoma: a randomized clinical trial.

Yang Zhang, Haiquan Chen, J. Xiang, 2015, JAMA surgery.

Comparative analysis of co-occurring mutations of specific tumor suppressor genes in lung adenocarcinoma between Asian and Caucasian populations

Yang Zhang, Haiquan Chen, Yongfu Yu, 2019, Journal of Cancer Research and Clinical Oncology.

Frequency and clinical significance of NF1 mutation in lung adenocarcinomas from East Asian patients

Yan-Ze Jin, Haiquan Chen, Yuan Li, 2018, International journal of cancer.

Synchronous Non-small Cell Lung Cancers: Diagnostic Yield can be Improved by Histologic and Genetic Methods

Yang Zhang, Yongfu Yu, Yihua Sun, 2014, Annals of Surgical Oncology.

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients

Bin Li, Yang Zhang, Lei Shen, 2015, Oncotarget.

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials

Haiquan Chen, Yongfu Yu, N. Zhao, 2013, OncoTargets and therapy.

Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: Long-term outcomes of a randomized clinical trial.

Yang Zhang, Haiquan Chen, Jialei Wang, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer

Lei Wang, William Pao, Bin Li, 2014, Clinical Cancer Research.

Meta‐analysis of lobectomy, segmentectomy, and wedge resection for stage I non‐small cell lung cancer

Yang Zhang, Haiquan Chen, Yihua Sun, 2015, Journal of surgical oncology.

Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients

Yang Zhang, Haiquan Chen, Yuan Li, 2014, OncoTargets and therapy.

The Histologic Classifications of Lung Adenocarcinomas Are Discriminable by Unique Lineage Backgrounds

Yang Zhang, Haiquan Chen, Yuan Li, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Changes in lung cancer incidence by sex and smoking status in China: a multicentre observational study

Yang Zhang, Yan-Ze Jin, Haiquan Chen, 2018, The Lancet.

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

H. Ji, Haiquan Chen, Q. Lu, 2014, OncoTargets and therapy.

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

H. Ji, Haiquan Chen, Q. Lu, 2014, OncoTargets and therapy.

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma

Yang Zhang, Haiquan Chen, Q. Lu, 2014, OncoTargets and therapy.

Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma

Yang Zhang, Haiquan Chen, Yongfu Yu, 2023, BMC Cancer.

Oncotargets and Therapy Dovepress

Haiquan Chen, Q. Lu, Yuan Li, 2022 .

Oncotargets and Therapy Dovepress Dovepress Sequential Treatment of Tyrosine Kinase Inhibitors and Chemotherapy for Egfr-mutated Non-small Cell Lung Cancer: a Meta-analysis of Phase Iii Trials

Haiquan Chen, Yongfu Yu, N. Zhao, 2022 .